Wealthfront Advisers LLC Makes New Investment in The Cooper Companies, Inc. $COO

Wealthfront Advisers LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, HoldingsChannel.com reports. The fund bought 8,430 shares of the medical device company’s stock, valued at approximately $605,000.

Several other institutional investors also recently made changes to their positions in COO. BlackRock Inc. acquired a new stake in shares of Cooper Companies during the 2nd quarter worth approximately $1,077,762,000. Wellington Management Group LLP boosted its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the period. Generation Investment Management LLP acquired a new position in Cooper Companies during the 4th quarter valued at approximately $233,539,000. Diamond Hill Capital Management Inc. grew its stake in Cooper Companies by 479.6% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after buying an additional 2,720,594 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares during the period. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. UBS Group initiated coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price objective on the stock. Needham & Company LLC decreased their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. Stifel Nicolaus cut their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Finally, Robert W. Baird reduced their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $76.22 on Friday. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $14.87 billion, a price-to-earnings ratio of 64.59, a PEG ratio of 1.99 and a beta of 0.83. The firm has a 50-day moving average of $71.93 and a two-hundred day moving average of $71.16.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.